Vanda Pharmaceuticals Files 8-K on Financials
Ticker: VNDA · Form: 8-K · Filed: May 7, 2025 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, disclosure
Related Tickers: VNDA
TL;DR
Vanda Pharma dropped an 8-K on May 7th detailing their financial results. Check it for the latest.
AI Summary
Vanda Pharmaceuticals Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037. The company is incorporated in Delaware and operates in the pharmaceutical preparations industry.
Why It Matters
This 8-K filing provides an update on Vanda Pharmaceuticals' financial condition and operational results, which is crucial information for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant new risks.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- May 7, 2025 (date) — Date of earliest event reported
- 2200 Pennsylvania Avenue NW Suite 300E Washington, DC 20037 (address) — Address of principal executive offices
- Delaware (jurisdiction) — State of incorporation
- 202-734-3400 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or conditions are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the excerpt.
When was this 8-K filing submitted?
The filing was submitted on May 7, 2025.
What is Vanda Pharmaceuticals Inc.'s principal executive office address?
The principal executive offices are located at 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037.
In which state is Vanda Pharmaceuticals Inc. incorporated?
Vanda Pharmaceuticals Inc. is incorporated in Delaware.
What is the SIC code for Vanda Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Vanda Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Vanda Pharmaceuticals Inc. (VNDA).